GlassScriptPhysician profile
Todd B Nelson
NPI 1306040050
$2,056.64
in general payments reported to CMS, 2019-2025
18 companies · $398 in 2025
The $398 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $222 · 2020: $17.22 · 2021: $280 · 2022: $301 · 2023: $506 · 2024: $332 · 2025: $398.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,121 · Education: $115.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,120.60 |
| Education | $115.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $474.92 | 2019-2025 | |
| Leo Pharma INC. | $287.93 | 2022-2025 | Adbry, Anzupgo |
| Pfizer INC. | $268.13 | 2019-2024 | |
| Novartis Pharmaceuticals Corporation | $266.80 | 2019-2025 | |
| Janssen Biotech, INC. | $157.65 | 2021-2025 | Tremfya |
| Organogenesis INC. | $137.83 | 2023-2024 | Puraply |
| Sun Pharmaceutical Industries INC. | $101.67 | 2019-2025 | Absorica Ld, Winlevi |
| Allergan, INC. | $71.60 | 2022 | |
| Genzyme Corporation | $68.89 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $56.15 | 2023-2024 | Sotyktu |
| Genentech USA, INC. | $47.44 | 2019-2022 | |
| Organon LLC | $29.80 | 2025 | Vtama |
| Dermira, INC. | $24.00 | 2019 | |
| Dermavant Sciences, INC. | $19.66 | 2023 | Vtama |
| Amgen INC. | $17.35 | 2025 | Otezla |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $12.18 | 2022 | |
| Helsinn Therapeutics (U.S.), INC. | $11.95 | 2019 | |
| Prugen, INC. Pharmaceuticals | $2.69 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Todd Nelson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.